T Saldeen. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsAntifibrinolytic Agents/pharmacologyAutopsyBlood Coagulation FactorsDogsFibrinFibrinolysisFibrinolytic Agents/bloodHeart Failure/bloodHumansHypoxia/bloodKidney/physiopathologyLung/blood supplyLung/pathologyLymph/metabolismPlasminogen Activators/antagonists & inhibitorsPlasminogen InactivatorsProstaglandins/metabolismPulmonary Embolism/bloodPulmonary Embolism/drug therapyPulmonary Embolism/pathologyPulmonary Veins/pathologyRespiration/drug effectsRespiratory Insufficiency/etiologySyndromeThrombin/pharmacologyWounds and Injuries/complications
Substances: See more » Antifibrinolytic AgentsBlood Coagulation FactorsFibrinolytic AgentsPlasminogen InactivatorsProstaglandinsFibrinPlasminogen ActivatorsThrombin
Year: 1976 PMID: 818479 DOI: 10.1016/0026-2862(76)90054-6
Source DB: PubMed Journal: Microvasc Res ISSN: 0026-2862 Impact factor: 3.514